Aryeh Jason
Insider CIK 1376960 · LFCR Director · MACK 10% owner · MYRX Director · ARLZ Director · OBIO Director · ANEB Director · IMMU Director · QLT Director · LGND Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2026-06-23 | 2026-06-25 | 42,553 | — | $0 | 42,553 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-11 | 2026-06-12 | 4,500 | $250.00 | $1.13M | 102,580 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2026-06-10 | 2026-06-12 | 500 | $250.00 | $125.0K | 107,080 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2026-06-05 | 2026-06-12 | 2,938 | — | $0 | 2,938 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2026-06-05 | 2026-06-12 | 836 | — | $0 | 107,580 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2026-06-04 | 2026-06-05 | 25,907 | — | $0 | 69,967 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | P Buy | 2026-05-18 | 2026-05-20 | 665 | $3.75 | $2.5K | 118,118 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | P Buy | 2026-05-15 | 2026-05-19 | 8,971 | $3.90 | $35.0K | 117,453 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2025-12-08 | 2025-12-08 | 2,034 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2025-12-08 | 2025-12-08 | 2,034 | $69.51 | $141.4K | 71,323 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-23 | 2025-09-24 | 4,628 | $170.96 | $791.2K | 70,243 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-23 | 2025-09-24 | 954 | $171.92 | $164.0K | 69,289 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2025-09-23 | 2025-09-24 | 4,418 | $170.41 | $752.9K | 74,871 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | P Buy | 2025-09-19 | 2025-09-19 | 1,000 | $2.45 | $2.5K | 108,482 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award | 2025-08-07 | 2025-08-08 | 15,000 | — | $0 | 107,482 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2025-07-15 | 2025-07-17 | 19,506 | — | $0 | 44,060 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2025-06-24 | 2025-06-27 | 36,797 | — | $0 | 36,797 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award | 2025-06-24 | 2025-06-27 | 12,422 | — | $0 | 92,482 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2025-06-06 | 2025-06-10 | 5,783 | — | $0 | 5,783 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2025-06-06 | 2025-06-10 | 1,209 | — | $0 | 79,289 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2025-04-04 | 2025-04-07 | 4,964 | — | $0 | 4,964 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2025-04-04 | 2025-04-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | M Exercise deriv | 2024-12-27 | 2024-12-30 | 11,700 | — | $0 | 6,900 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | M Exercise | 2024-12-27 | 2024-12-30 | 11,700 | $4.30 | $50.3K | 80,060 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2024-08-19 | 2024-08-21 | 24,554 | — | $0 | 24,554 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2024-06-20 | 2024-06-21 | 17,068 | — | $0 | 17,068 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award | 2024-06-20 | 2024-06-21 | 5,376 | — | $0 | 68,360 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2024-06-14 | 2024-06-18 | 5,444 | — | $0 | 5,444 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2024-06-14 | 2024-06-18 | 1,252 | — | $0 | 78,080 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2024-06-13 | 2024-06-17 | 2,482 | — | $0 | 2,482 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2024-06-13 | 2024-06-17 | 41,667 | — | $0 | 41,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-04-30 | 2024-05-02 | 2,406 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-04-30 | 2024-05-02 | 2,406 | $52.30 | $125.8K | 76,828 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2024-03-05 | 2024-03-06 | 2,893 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2024-03-05 | 2024-03-06 | 2,893 | $39.35 | $113.8K | 74,422 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-07-20 | 2023-07-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2023-06-09 | 2023-06-13 | 5,461 | — | $0 | 5,461 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2023-06-09 | 2023-06-13 | 1,142 | — | $0 | 71,529 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | M Exercise deriv | 2023-04-12 | 2023-05-05 | 11,246 | — | $0 | 11,246 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | M Exercise | 2023-04-12 | 2023-05-05 | 11,246 | — | $0 | 62,984 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-01-26 | 2023-05-05 | 22,492 | — | $0 | 22,492 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-01-26 | 2023-05-19 | 23,250 | — | $0 | 23,250 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-01-26 | 2023-01-30 | 18,600 | — | $0 | 18,600 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-01-26 | 2023-01-30 | 23,250 | — | $0 | 23,250 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award deriv | 2023-01-26 | 2023-01-30 | 6,975 | — | $0 | 6,975 | SEC↗ |
| OBIO Orchestra BioMed Holdings, | A Award | 2023-01-26 | 2023-01-30 | 51,738 | — | $0 | 51,738 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-12-22 | 2022-12-27 | 4,484 | — | $0 | 4,484 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2022-06-10 | 2022-06-13 | 4,340 | — | $0 | 4,340 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2022-06-10 | 2022-06-13 | 1,004 | — | $0 | 69,668 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2022-04-21 | 2022-10-03 | 30,425 | — | $0 | 30,425 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2021-06-04 | 2021-06-07 | 3,269 | — | $0 | 3,269 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2021-06-04 | 2021-06-07 | 630 | — | $0 | 68,664 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2020-06-10 | 2020-06-12 | 2,468 | — | $0 | 2,468 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2020-06-10 | 2020-06-12 | 831 | — | $0 | 68,034 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-04 | 750 | $87.01 | $65.3K | 67,203 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-08-05 | 2019-08-06 | 746 | $90.01 | $67.1K | 66,453 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-07-31 | 2019-07-31 | 754 | $93.00 | $70.1K | 65,707 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-07-30 | 2019-07-31 | 3,000 | $100.22 | $300.7K | 64,953 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-07-29 | 2019-07-31 | 250 | $106.01 | $26.5K | 61,953 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | P Buy | 2019-07-16 | 2019-07-18 | 302 | $5.44 | $1.6K | 3,802 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | P Buy | 2019-07-12 | 2019-07-15 | 1,000 | $5.62 | $5.6K | 3,500 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | P Buy | 2019-07-12 | 2019-07-15 | 2,400 | $5.71 | $13.7K | 2,500 | SEC↗ |
| MACK MERRIMACK PHARMACEUTICALS | P Buy | 2019-07-11 | 2019-07-15 | 100 | $5.71 | $571 | 100 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-06-11 | 2019-06-12 | 250 | $107.01 | $26.8K | 61,703 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2019-06-06 | 2019-06-07 | 4,071 | — | $0 | 4,071 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2019-06-06 | 2019-06-07 | 835 | — | $0 | 61,453 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-31 | 2019-05-31 | 500 | $108.51 | $54.3K | 60,618 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-30 | 2019-05-31 | 250 | $110.01 | $27.5K | 60,118 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-29 | 2019-05-31 | 250 | $111.01 | $27.8K | 59,868 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-20 | 2019-05-22 | 250 | $112.01 | $28.0K | 59,618 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-05-14 | 2019-05-16 | 250 | $112.51 | $28.1K | 59,368 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2019-03-13 | 2019-03-15 | 202 | $112.51 | $22.7K | 51,594 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-17 | 2018-08-17 | 26,862 | $241.81 | $6.50M | 51,392 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-08-16 | 2018-08-17 | 1,080 | $245.00 | $264.6K | 78,254 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-07-03 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2018-06-19 | 2018-06-21 | 2,474 | — | $0 | 2,474 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2018-06-19 | 2018-06-21 | 493 | — | $0 | 59,118 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-03-09 | 2018-03-09 | 4,000 | $176.47 | $705.9K | 79,334 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-03-08 | 2018-03-09 | 3,500 | $174.88 | $612.1K | 83,334 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2018-02-26 | 2018-02-27 | 1,000 | — | $0 | 58,625 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2018-02-23 | 2018-02-27 | 3,417 | $155.00 | $529.6K | 86,834 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-11-17 | 2017-11-20 | 24,400 | $140.22 | $3.42M | 90,251 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-08-23 | 2017-08-25 | 2,000 | $127.99 | $256.0K | 114,651 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2017-05-25 | 2017-05-26 | 2,456 | $113.50 | $278.8K | 2,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2017-05-25 | 2017-05-26 | 666 | — | $0 | 59,625 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-05-23 | 2017-05-24 | 104,176 | $1.41 | $146.9K | 0 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-05-22 | 2017-05-24 | 233,468 | $1.42 | $331.5K | 104,176 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | S Sale | 2017-05-19 | 2017-05-24 | 51,041 | $1.56 | $79.6K | 337,644 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | P Buy | 2017-05-15 | 2017-05-17 | 361 | $8.95 | $3.2K | 242,433 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-05-12 | 2017-05-12 | 14,582 | $111.87 | $1.63M | 116,651 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-05-11 | 2017-05-12 | 22,665 | $110.04 | $2.49M | 131,233 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2017-05-11 | 2017-05-12 | 7,500 | — | $0 | 15,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-02-28 | 2017-02-28 | 7,000 | $107.58 | $753.1K | 153,898 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2017-02-27 | 2017-02-28 | 25,000 | $106.00 | $2.65M | 160,898 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2017-01-08 | 2017-01-10 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-22 | 2016-12-27 | 9,600 | — | $0 | 9,600 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 175,979 | — | $0 | 637,457 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 1,136,363 | $1.76 | $2.00M | 1,210,363 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 31,280 | — | $0 | 31,280 | SEC↗ |
| NVLN QLT INC/BC | A Award | 2016-11-29 | 2016-12-01 | 82,765 | — | $0 | 82,765 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-11-25 | 2016-11-25 | 3,478 | $106.96 | $372.0K | 185,898 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-11-22 | 2016-11-25 | 15,001 | $107.40 | $1.61M | 189,376 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-11-18 | 2016-11-18 | 5,000 | $105.00 | $525.0K | 204,377 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-11-16 | 2016-11-18 | 1,330 | $106.33 | $141.4K | 209,377 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2016-09-16 | 2017-04-25 | 295,929 | $5.86 | $1.73M | 343,216 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 12,800 | — | $0 | 56,800 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2016-06-17 | 2016-06-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2016-06-16 | 2016-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-06-16 | 2016-06-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2016-05-23 | 2016-05-25 | 2,329 | $119.30 | $277.8K | 2,329 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2016-05-23 | 2016-05-25 | 622 | — | $0 | 58,959 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-05-06 | 2016-05-09 | 15,000 | $118.52 | $1.78M | 210,707 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-05-05 | 2016-05-09 | 10,000 | $120.21 | $1.20M | 225,707 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-03-08 | 2016-03-09 | 500 | $102.49 | $51.2K | 235,707 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2016-03-07 | 2016-03-09 | 5,629 | $101.07 | $568.9K | 236,207 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2015-12-29 | 2015-12-30 | 400 | $2.49 | $996 | 461,478 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2015-12-29 | 2015-12-30 | 18,000 | $2.50 | $45.0K | 461,078 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-11-11 | 2015-11-13 | 3,000 | $101.49 | $304.5K | 241,836 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-30 | 2015-07-01 | 25,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-30 | 2015-07-01 | 25,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-30 | 2015-07-01 | 25,000 | $3.27 | $81.8K | 74,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-30 | 2015-07-01 | 25,000 | $3.64 | $91.0K | 49,000 | SEC↗ |
| QLTI QLT INC/BC | P Buy | 2015-06-16 | 2015-06-18 | 288,000 | $3.47 | $999.4K | 288,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 8,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2015-06-07 | 2015-06-09 | 12,000 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 12,000 | — | $0 | 179,078 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2015-06-07 | 2015-06-09 | 8,000 | — | $0 | 167,078 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-06-04 | 2015-06-08 | 1,640 | $92.68 | $152.0K | 244,836 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-20 | 2015-05-20 | 1,000 | $87.65 | $87.7K | 246,476 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-19 | 2015-05-20 | 2,240 | $88.82 | $199.0K | 247,476 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-18 | 2015-05-20 | 6,000 | $86.74 | $520.4K | 249,716 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-04-24 | 2015-04-27 | 2,754 | $89.75 | $247.2K | 2,754 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-04-24 | 2015-04-27 | 925 | — | $0 | 58,337 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | G Gift | 2014-12-31 | 2015-01-05 | 3,283 | — | $0 | 57,412 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2014-12-17 | 2014-12-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise deriv | 2014-12-15 | 2014-12-17 | 4,000 | — | $0 | 8,000 | SEC↗ |
| QLTI QLT INC/BC | M Exercise | 2014-12-15 | 2014-12-17 | 4,000 | — | $0 | 4,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2014-10-09 | 2014-10-09 | 11,000 | $42.99 | $472.9K | 255,716 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-10-01 | 2014-10-01 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-10-01 | 2014-10-01 | 7,335 | $32.30 | $236.9K | 60,695 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-09-25 | 2014-09-29 | 630 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-09-25 | 2014-09-29 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-09-25 | 2014-09-29 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-09-25 | 2014-09-29 | 7,335 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-09-25 | 2014-09-29 | 2,500 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-09-25 | 2014-09-29 | 630 | $6.82 | $4.3K | 33,690 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-09-25 | 2014-09-29 | 7,335 | $12.53 | $91.9K | 41,025 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-09-25 | 2014-09-29 | 2,500 | $8.58 | $21.4K | 46,025 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-09-25 | 2014-09-29 | 7,335 | $10.12 | $74.2K | 53,360 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-09-25 | 2014-09-29 | 2,500 | $17.88 | $44.7K | 43,525 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-06-04 | 2014-06-05 | 3,312 | $67.53 | $223.7K | 3,312 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 666 | — | $0 | 33,060 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-06-04 | 2014-06-05 | 1,151 | — | $0 | 32,394 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-14 | 2014-02-14 | 9,500 | $78.87 | $749.3K | 244,716 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-13 | 2014-02-14 | 6,700 | $77.43 | $518.8K | 254,216 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 24,120 | $75.21 | $1.81M | 260,916 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2013-07-15 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 7,335 | $32.30 | $236.9K | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-06-11 | 2013-06-12 | 2,925 | — | $0 | 31,243 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-06-04 | 2013-06-06 | 34 | $40.00 | $1.4K | 371 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-06-04 | 2013-06-07 | 34 | $40.00 | $1.4K | 371 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-05-24 | 2013-05-28 | 50 | $40.00 | $2.0K | 337 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-05-17 | 2013-05-21 | 50 | $40.00 | $2.0K | 250 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-05-17 | 2013-05-21 | 37 | $40.00 | $1.5K | 287 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-05-03 | 2013-05-07 | 100 | $0.45 | $45 | 100 | SEC↗ |
| QLTI QLT INC/BC | S Sale deriv | 2013-05-03 | 2013-05-07 | 100 | $0.40 | $40 | 200 | SEC↗ |
| QLTI QLT INC/BC | E Expire deriv | 2012-12-22 | 2012-12-26 | 125 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | E Expire deriv | 2012-12-22 | 2012-12-26 | 330 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | X Exercise deriv | 2012-10-11 | 2012-10-15 | 500 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | X Exercise | 2012-10-11 | 2012-10-15 | 500 | $10.00 | $5.0K | 155,078 | SEC↗ |
| QLTI QLT INC/BC | E Expire deriv | 2012-09-22 | 2012-09-25 | 20 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | X Exercise deriv | 2012-09-22 | 2012-09-25 | 10 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | E Expire deriv | 2012-09-22 | 2012-09-25 | 210 | — | $0 | 0 | SEC↗ |
| QLTI QLT INC/BC | X Exercise | 2012-09-22 | 2012-09-25 | 1,000 | $10.00 | $10.0K | 154,578 | SEC↗ |
| QLTI QLT INC/BC | A Award deriv | 2012-07-10 | 2012-07-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-06-18 | 2012-06-20 | 3,000 | $2.29 | $6.9K | 545,245 | SEC↗ |
| QLT QLT INC/BC | E Expire deriv | 2012-06-16 | 2012-06-19 | 20 | — | $0 | 0 | SEC↗ |
| QLT QLT INC/BC | X Exercise deriv | 2012-06-16 | 2012-06-19 | 25 | — | $0 | 0 | SEC↗ |
| QLT QLT INC/BC | E Expire deriv | 2012-06-16 | 2012-06-19 | 447 | — | $0 | 0 | SEC↗ |
| QLT QLT INC/BC | X Exercise | 2012-06-16 | 2012-06-19 | 2,500 | $10.00 | $25.0K | 153,578 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-06-15 | 2012-06-18 | 1,025 | $2.35 | $2.4K | 542,245 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-06-14 | 2012-06-18 | 4,000 | $2.36 | $9.4K | 541,220 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-06-07 | 2012-06-11 | 1,116 | $2.40 | $2.7K | 537,220 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2012-06-01 | 2012-06-05 | 700 | $11.98 | $8.4K | 285,036 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-05-31 | 2012-05-31 | 7,335 | — | $0 | 7,335 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 2,925 | — | $0 | 24,726 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-05-31 | 2012-05-31 | 3,592 | — | $0 | 28,318 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-31 | 2012-06-01 | 10,133 | $2.35 | $23.8K | 536,104 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-30 | 2012-06-01 | 4,020 | $2.47 | $9.9K | 525,971 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-25 | 2012-05-25 | 153 | $2.47 | $378 | 521,951 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-23 | 2012-05-25 | 1,000 | $2.47 | $2.5K | 521,798 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-22 | 2012-05-23 | 262 | $2.46 | $645 | 520,798 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-21 | 2012-05-23 | 12,000 | $2.51 | $30.1K | 520,536 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-18 | 2012-05-21 | 7,168 | $2.60 | $18.6K | 508,536 | SEC↗ |
| MYRX Myrexis, Inc. | P Buy | 2012-05-17 | 2012-05-21 | 3,832 | $2.61 | $10.0K | 501,368 | SEC↗ |
| MYRX Myrexis, Inc. | E Expire deriv | 2012-03-17 | 2012-03-20 | 20 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-03-17 | 2012-03-20 | 10 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-03-17 | 2012-03-20 | 10 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise | 2012-03-17 | 2012-03-20 | 2,000 | $5.00 | $10.0K | 497,536 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 10 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 20 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 10 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 25 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 20 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise deriv | 2012-01-31 | 2012-02-01 | 10 | — | $0 | 0 | SEC↗ |
| MYRX Myrexis, Inc. | X Exercise | 2012-01-31 | 2012-02-01 | 9,500 | $5.00 | $47.5K | 495,536 | SEC↗ |